TCL Archive NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation October 21, 1994
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive With $10.4 Billion To Spend In 18 Months, NIH Says Money Will Be Spent Rationally. Funds Will Support R01s February 20, 2009
